{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:50:57Z","timestamp":1759384257392,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["Grand No. SZSM201612006"],"award-info":[{"award-number":["Grand No. SZSM201612006"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12888-018-1655-5","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T08:29:56Z","timestamp":1520929796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy"],"prefix":"10.1186","volume":"18","author":[{"given":"Yuanhan","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haichen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"1655_CR1","volume-title":"The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research","author":"World Health Organization","year":"1993","unstructured":"World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993."},{"key":"1655_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 2013."},{"key":"1655_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4137\/JCNSD.S38359","volume":"8","author":"AM Rapp","year":"2016","unstructured":"Rapp AM, Bergman RL, Piacentini J, McGuire JF. Evidence-based assessment of obsessive\u2013compulsive disorder. J Cent Nerv Syst Dis. 2016;8:13\u201329. \n                    https:\/\/doi.org\/10.4137\/JCNSD.S38359\n                    \n                  .","journal-title":"J Cent Nerv Syst Dis"},{"issue":"7","key":"1655_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1176\/appi.ajp.160.7.1233","volume":"160","author":"MA Taylor","year":"2003","unstructured":"Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160(7):1233\u201341. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.160.7.1233\n                    \n                  .","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1655_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00406-013-0410-7","volume":"264","author":"JE Wilson","year":"2014","unstructured":"Wilson JE, Nian H, Heckers S. The schizoaffective disorder diagnosis: a conundrum in the clinical setting. Eur Arch Psychiatry Clin Neurosci. 2014;264(1):29\u201334. \n                    https:\/\/doi.org\/10.1007\/s00406-013-0410-7\n                    \n                  .","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"1655_CR6","first-page":"1519","volume":"59","author":"N Motohashi","year":"2001","unstructured":"Motohashi N. Selective serotonin reuptake inhibitor (SSRI). Nihon Rinsho. 2001;59(8):1519\u201322.","journal-title":"Nihon Rinsho"},{"issue":"8","key":"1655_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","volume":"3","author":"P Skapinakis","year":"2016","unstructured":"Skapinakis P, Caldwell DM, Hollingworth W, Bryden P, Fineberg NA, Salkovskis P, et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2016;3(8):730\u20139. \n                    https:\/\/doi.org\/10.1016\/S2215-0366(16)30069-4\n                    \n                  .","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"1655_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40258-014-0095-8","volume":"12","author":"S Karve","year":"2014","unstructured":"Karve S, Markowitz M, Fu DJ, Lindenmayer JP, Wang CC, Candrilli SD, et al. Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder. Appl Health Econ Health Policy. 2014;12(3):335\u201346. \n                    https:\/\/doi.org\/10.1007\/s40258-014-0095-8\n                    \n                  .","journal-title":"Appl Health Econ Health Policy"},{"issue":"4","key":"1655_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/schbul\/17.4.649","volume":"17","author":"P Plasky","year":"1991","unstructured":"Plasky P. Antidepressant usage in schizophrenia. Schizophr Bull. 1991;17(4):649\u201357.","journal-title":"Schizophr Bull"},{"key":"1655_CR10","unstructured":"Petit M. Antidepressive drug treatment of the schizophrenic patient. Enc\u00e9phale. 1994;20 Spec No 4:667\u2013674."},{"issue":"2 Suppl","key":"1655_CR11","first-page":"1","volume":"161","author":"AF Lehman","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J, American Psychiatric Association. Steering committee on practice guidelines. Practice guidelines for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 Suppl):1\u201356.","journal-title":"Am J Psychiatry"},{"key":"1655_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fpsyt.2014.00181","volume":"5","author":"P Sienaert","year":"2014","unstructured":"Sienaert P, Dhossche DM, Vancampfort D, De Hert M, Gazdag G. A clinical review of the treatment of catatonia. Front Psychiatry. 2014;5:181. \n                    https:\/\/doi.org\/10.3389\/fpsyt.2014.00181\n                    \n                  .","journal-title":"Front Psychiatry"},{"issue":"1","key":"1655_CR13","doi-asserted-by":"publisher","first-page":"e0170452","DOI":"10.1371\/journal.pone.0170452","volume":"12","author":"CC Lin","year":"2017","unstructured":"Lin CC, Hung YY, Tsai MC, Huang TL. The lorazepam and diazepam protocol for catatonia due to general medical condition and substance in liaison psychiatry. PLoS One. 2017;12(1):e0170452. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0170452\n                    \n                  .","journal-title":"PLoS One"},{"issue":"8","key":"1655_CR14","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.comppsych.2013.06.003","volume":"54","author":"CC Lin","year":"2013","unstructured":"Lin CC, Huang TL. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry. 2013;54(8):1210\u20134. \n                    https:\/\/doi.org\/10.1016\/j.comppsych.2013.06.003\n                    \n                  .","journal-title":"Compr Psychiatry"},{"issue":"1","key":"1655_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/2319-4170.107162","volume":"36","author":"YC Huang","year":"2013","unstructured":"Huang YC, Lin CC, Hung YY, Huang TL. Rapid relief of catatonia in mood disorder by lorazepam and diazepam. Biom J. 2013;36(1):35\u20139. \n                    https:\/\/doi.org\/10.4103\/2319-4170.107162\n                    \n                  .","journal-title":"Biom J"},{"issue":"4","key":"1655_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1055\/s-0043-106436","volume":"50","author":"R Schennach","year":"2017","unstructured":"Schennach R, Obermeier M, Seem\u00fcller F, J\u00e4ger M, Schmauss M, Laux G, et al. Add-on antidepressants in the naturalistic treatment of schizophrenia spectrum disorder \u2013 when, who, and how? Pharmacopsychiatry. 2017;50(4):136\u201344. \n                    https:\/\/doi.org\/10.1055\/s-0043-106436\n                    \n                  .","journal-title":"Pharmacopsychiatry"},{"key":"1655_CR17","doi-asserted-by":"publisher","unstructured":"Terevnikov V, Joffe G, Stenberg JH. Randomized controlled trials of add-on antidepressants in schizophrenia. Int J Neuropsychopharmacol. 2015;18(9) \n                    https:\/\/doi.org\/10.1093\/ijnp\/pyv049\n                    \n                  .","DOI":"10.1093\/ijnp\/pyv049"},{"issue":"6 Pt 1","key":"1655_CR18","first-page":"481","volume":"28","author":"N Pommepuy","year":"2002","unstructured":"Pommepuy N, Januel D. Catatonia: resurgence of a concept. A review of the international literature. Enc\u00e9phale. 2002;28(6 Pt 1):481\u201392.","journal-title":"Enc\u00e9phale"},{"issue":"3","key":"1655_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/0253-7176.207338","volume":"39","author":"SP Swain","year":"2017","unstructured":"Swain SP, Behura SS, Dash MK. The phenomenology and treatment response in catatonia: a hospital based descriptive study. Indian J Psychol Med. 2017;39(3):323\u20139. \n                    https:\/\/doi.org\/10.4103\/0253-7176.207338\n                    \n                  .","journal-title":"Indian J Psychol Med"},{"issue":"4","key":"1655_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1176\/jnp.2009.21.4.371","volume":"21","author":"J Daniels","year":"2009","unstructured":"Daniels J. Catatonia: clinical aspects and neurobiological correlates. J Neuropsychiatr Clin Neuro Sci. 2009;21(4):371\u201380. \n                    https:\/\/doi.org\/10.1176\/jnp.2009.21.4.371\n                    \n                  .","journal-title":"J Neuropsychiatr Clin Neuro Sci"},{"key":"1655_CR21","volume-title":"Perspectives on catatonia: 2 decades of personal clinical experience. 10th world congress of biological psychiatry. Prague","author":"PI Rosebush","year":"2011","unstructured":"Rosebush PI. Perspectives on catatonia: 2 decades of personal clinical experience. 10th world congress of biological psychiatry. Prague; 2011."},{"issue":"3","key":"1655_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/jnnp.58.3.271","volume":"58","author":"PF Buckley","year":"1995","unstructured":"Buckley PF, Hutchinson M. Neuroleptic malignant syndrome. J Neurol Neurosurg Psychiatry. 1995;58(3):271\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1655_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.23.2.jnp223","volume":"23","author":"ML England","year":"2011","unstructured":"England ML, Ong\u00fcr D, Konopaske GT, Karmacharya R. Catatonia in psychotic patients: clinical features and treatment response. J Neuropsychiatry Clin Neurosci. 2011;23(2):223\u20136. \n                    https:\/\/doi.org\/10.1176\/jnp.23.2.jnp223\n                    \n                  .","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"1655_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5498\/wjp.v5.i2.182","volume":"5","author":"F Luchini","year":"2015","unstructured":"Luchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: efficacy and predictors of response. World J Psychiatry. 2015;5(2):182\u201392. \n                    https:\/\/doi.org\/10.5498\/wjp.v5.i2.182\n                    \n                  .","journal-title":"World J Psychiatry"},{"issue":"5","key":"1655_CR25","first-page":"379","volume":"66","author":"P Br\u00e4unig","year":"1995","unstructured":"Br\u00e4unig P, Kr\u00fcger S, H\u00f6ffler J. Exacerbation of catatonic symptoms in neuroleptic therapy. Nervenarzt. 1995;66(5):379\u201382.","journal-title":"Nervenarzt"},{"issue":"2","key":"1655_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/schbul\/sbp141","volume":"36","author":"PI Rosebush","year":"2010","unstructured":"Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull. 2010;36(2):239\u201342. \n                    https:\/\/doi.org\/10.1093\/schbul\/sbp141\n                    \n                  .","journal-title":"Schizophr Bull"},{"issue":"5\u20136","key":"1655_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.eurpsy.2005.03.012","volume":"20","author":"F Van Den Eede","year":"2005","unstructured":"Van Den Eede F, Van Hecke J, Van Dalfsen A, Van den Bossche B, Cosyns P, Sabbe BG. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry. 2005;20(5\u20136):422\u20139. \n                    https:\/\/doi.org\/10.1016\/j.eurpsy.2005.03.012\n                    \n                  .","journal-title":"Eur Psychiatry"},{"issue":"12","key":"1655_CR28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/NMD.0b013e3182392d7e","volume":"199","author":"E Grenier","year":"2011","unstructured":"Grenier E, Ryan M, Ko E, Fajardo K, John V. Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report. J Nerv Ment Dis. 2011;199(12):987\u20138. \n                    https:\/\/doi.org\/10.1097\/NMD.0b013e3182392d7e\n                    \n                  .","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"1655_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/01.WNF.0000220816.86478.84","volume":"29","author":"QR Tan","year":"2006","unstructured":"Tan QR, Wang W, Wang HH, Zhang RG, Guo L, Zhang YH. Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report. Clin Neuropharmacol. 2006;29(3):154\u20136. \n                    https:\/\/doi.org\/10.1097\/01.WNF.0000220816.86478.84\n                    \n                  .","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"1655_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1176\/appi.ps.52.6.805","volume":"52","author":"BL Svarstad","year":"2001","unstructured":"Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv. 2001;52(6):805\u201311. \n                    https:\/\/doi.org\/10.1176\/appi.ps.52.6.805\n                    \n                  .","journal-title":"Psychiatr Serv"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-018-1655-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T20:05:27Z","timestamp":1552421127000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-018-1655-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1186\/s12888-018-1655-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"15 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"For the publication of this case report, written informed consent was obtained from the patient and his older sister.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We have no conflicts of interest to declare with respect to the manuscript, including no financial, consultant, political, personal, religious, ideological, academic, intellectual, or other relationships that could lead to a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"67"}}